http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-200738734-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c76ecadad74a1a35270b3e3a34d60f37
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
filingDate 2006-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5399c296260fc9d2376ad14202443898
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f4f01d68501284fa753c98b6caa4a84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fe7e2c144bfb836b7f0563c34bea5f6
publicationDate 2007-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-200738734-A
titleOfInvention Benzoate salt of 4-(5-methyl-oxazolo[4,5-b]pyridin-2-yl)-1,4-diaza-bicyclo[3.2.2]nonane
abstract The present invention provides a benzoate salt of Formula I: Formula I is also known as 4-(5-methyloxazolo[4,5-b]pyridine-2-yl)-1,4-diazabicyclo[3.2.2]nonane. The benzoate salt of the invention is useful in the treatment of schizophrenia and Alzheimer's Disease. It is particularly of use in the treatment of cognitive deficits associated with schizophrenia, cognitive and attention deficit symptoms of Alzheimer's Disease, and neurodegeneration associated with Alzheimer's Disease.
priorityDate 2005-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420406589
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11184481

Total number of triples: 19.